Table 3. Combined neurosurgical intervention and mortality patient subset.
Fall was defined as greater than ground level.
ASA, aspirin; X Inhibitory, factor X inhibitor; Thrombin, direct thrombin inhibitor; NSAID, non-steroidal anti-inflammatory drug; Vit K, vitamin K; FFP, fresh frozen plasma; PCC, prothrombin complex concentrate; Cryo, cryoprecipitate; VII, factor VII; Plts; platelets; GLF, ground-level fall; MVC, motor vehicle collision
Anti-Coagulation | Reversal Agents | Mechanism of Injury |
ASA: 22.9% (16/70) | Vit K: 7.1% (5/70) | GLF: 72.9% (51/70) |
Plavix: 7.1% (5/70) | FFP: 12.9% (9/70) | Fall: 8.6% (6/70) |
Coumadin: 8.6% (6/70) | PCC: 4.3% (3/70) | MVC: 7.1% (5/70) |
X Inhibitor: 1.4% (1/70) | Cryo: 1.4% (1/70) | Assault: 7.1% (5/70) |
Thrombin: 0% (0/70) | VII: 0% (0/70) | Other: 4.3% (3/70) |
NSAID: 0% (0/70) | Plts: 11.4% (8/70) | |
None: 64.3% (45/70) | Other: 0% (0/70) | |
None: 75.7% (53/70) |